MedPath
NMPA Approval

Drospirenone and Ethinylestradiol Tablets(Ⅱ)

国药准字HJ20140972

October 30, 2023

H20140972

Drug Information

屈螺酮炔雌醇片(Ⅱ)

片剂

炔雌醇0.020mg和屈螺酮3.000mg

化学药品

October 30, 2023

October 29, 2028

Company Information

Applicant Company

875 Pacific Highway PYMBLE NSW 2073 Australia

Manufacturing Company

Dobereinerstraβe 20, 99427 Weimar, Thuringia, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

屈螺酮炔雌醇片(Ⅱ) - NMPA 批准文号 | MedPath